kimberly...@gmail.com
unread,Nov 17, 2015, 6:52:50 PM11/17/15You do not have permission to delete messages in this group
Sign in to report message
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
to
On Sunday, May 9, 1999 at 12:00:00 AM UTC-7, Anonymous wrote:
> J Urol 1999 Feb;161(2):558-65
>
> A randomized double-blind trial of oral L-arginine for treatment
> of interstitial cystitis.
>
> Korting GE, Smith SD, Wheeler MA, Weiss RM, Foster HE Jr
>
> Department of Surgery, Yale University School of Medicine, New
> Haven, Connecticut 06520-8041, USA.
>
> PURPOSE: Nitric oxide synthase activity is decreased in the
> urine of patients with interstitial cystitis compared to the
> urine of controls. In a preliminary trial oral L-arginine, the
> substrate for nitric oxide synthase, increased urinary nitric
> oxide synthase activity and improved interstitial cystitis
> symptoms. This randomized, double-blind, placebo controlled
> study further investigates the efficacy of L-arginine treatment
> for interstitial cystitis. MATERIALS AND METHODS: A total of 53
> interstitial cystitis patients were assigned to receive daily
> 1,500 mg. L-arginine or placebo orally for 3 months.
> Interstitial cystitis symptoms were assessed by interviews at 2
> weeks, and 1, 2 and 3 months. RESULTS: The trial was completed
> by 21 of 27 patients in the L-arginine group and 25 of 26 in the
> placebo group. Using per protocol analysis 29% (6 of 21
> patients) in the L-arginine group and 8% (2 of 25) in the
> placebo group were clinically improved by the end of the trial
> (p = 0.07). A Likert scale showed greater global improvement in
> the L-arginine group (48%, 10 of 21) compared to the placebo
> group (24%, 6 of 25) at 3 months (p = 0.05) with a decrease in
> pain intensity (p = 0.04), and tendency toward improvement in
> urgency (p = 0.06) and frequency of pain (p = 0.09). Using an
> intention to treat approach to analysis there were no
> differences between groups. CONCLUSIONS: Oral L-arginine (1,500
> mg. daily) may decrease pain and urgency in a subset of
> interstitial cystitis patients.
>
> Publication Types:
>
> Clinical trial Randomized controlled trial
>
> PMID: 9915448, UI: 99112654
What does this actually mean? My mom purchased this for me to take but I am afraid to take anything new. Chronic pain from ic and pelvic pain is severe.